Tocilizumab in refractory takayasu arteritis. open-label national multicenter study of 53 patients of clinical practice

Authors
Category Primary study
JournalAnnals of the Rheumatic Diseases
Year 2020
This article has no abstract
Epistemonikos ID: 339c127dc598f16da9dfee4ebf2866eb5a9de04d
First added on: Feb 12, 2025